New DoseSpot Analysis of 100,000 GLP-1 Prescriptions Finds That Patients Overpaid by $10.2M Collectively

92 percent of prescriptions could have been filled at a lower price, with better information on pricing, dispensing options and manufacturer cost-savings programs  DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102,166 GLP-1 prescriptions the company processed in Q1 2025. […]

✨ GLP-1s and Post-Weight Loss Plastic Surgery Trends

There is growing evidence—especially in the plastic surgery community—that the recent surge in GLP‑1 medications (like Ozempic, Wegovy, Mounjaro) for weight loss is fueling a wave of “trim & sculpt” surgeries to address excess skin and volume loss. 📈 Trend & Clinical ReviewsThe American Society of Plastic Surgeons and multiple industry blogs report an increase […]

Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue

Abstract Aims Glucagon-like peptide 1 (GLP-1) is a gastrointestinal hormone with pleiotropic functions, including vasodilatory and vasculoprotective effects. As GLP-1 increases after a meal, it could be involved in adipose tissue blood flow (ATBF) regulation. In one-third of healthy people, the postprandial ATBF response to meals is blunted. Whether this responder/non-responder phenomenon stems from an […]

Opinion: STAT+: How to evaluate GLP-1s and Medicare costs? Here’s one idea

Today, more than 40% of adults over 60 are considered obese, fueling chronic disease and straining Medicare’s budget. With the price tag for obesity-related care rising, some experts suggest covering GLP-1 medications for weight loss through Medicare could save billions, citing data that estimates Medicare spending could drop by $1,262 to $5,442 annually per beneficiary […]